ACKERMAN JOEL sold ~$20M in DaVita HealthCare Partners Inc stock
DaVita HealthCare Partners Inc (DVA) · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
Trade Details · Public SEC Filing
Insider
ACKERMAN JOEL
Role
—
Transaction
Open-Market Sale
Approx. Value
~$20M
Trade Date
May 7, 2026
Company
DaVita HealthCare Partners Inc
Ticker
DVASource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$20M sale
Trades over $1M are rare. When insiders put this much of their own money on the line, they tend to have high conviction in their company's direction.
How good is ACKERMAN JOEL at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
On May 7, 2026, ACKERMAN JOEL — a corporate insider at DaVita HealthCare Partners Inc — filed a Form 4 with the SEC disclosing an open-market sale of approximately ~$20M in DaVita HealthCare Partners Inc (DVA) stock.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time ACKERMAN JOEL trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More DVA Insider Activity
HEARTY JAMES O
May 15, 2026
~$2.9M
VS
BERKSHIRE HATHAWAY INC
May 12, 2026
~$197M
VS
Maughan David Paul
May 12, 2026
~$2.7M
VS
Maughan David Paul
May 11, 2026
~$1.4M
VS
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free